Phyllodes tumour. State of the art
Keywords:
Phyllodes tumour, Breast neoplasms, Classification, Pathology, Surgery, Drug therapy, RadiotherapyAbstract
Phyllodes tumour is a fibroepithelial neoplasm of the breast, with a low world incidence, and with few prospective trials on its diagnosis and treatment. A review is presented of the available world medical literature on this topic. Phyllodes tumours can currently be classified as benign, borderline and malign. This classification helps to determine the surgical treatment, which is the cornerstone of the treatment of Phyllodes tumour, as well as the adjuvant treatment, and finally it helps to determine the patient’s prognosis.
Author Biographies
Diego Corso, Instituto Nacional de Cancerología
Clínica de Seno y Tejidos Blandos, Instituto Nacional de Cancerología, Bogotá D. C., Colombia
Daniel Contreras, Instituto Nacional de Cancerología
Clínica de Seno y Tejidos Blandos, Instituto Nacional de Cancerología, Bogotá D. C., Colombia
Ángel Javier, Instituto Nacional de Cancerología
Clínica de Seno y Tejidos Blandos, Instituto Nacional de Cancerología, Bogotá D. C., Colombia
Luis Guzmán, Instituto Nacional de Cancerología
Clínica de Seno y Tejidos Blandos, Instituto Nacional de Cancerología, Bogotá D. C., Colombia
Sandra Díaz, Instituto Nacional de Cancerología
Clínica de Seno y Tejidos Blandos, Instituto Nacional de Cancerología, Bogotá D. C., Colombia
Oscar García, Instituto Nacional de Cancerología
Clínica de Seno y Tejidos Blandos, Instituto Nacional de Cancerología, Bogotá D. C., Colombia
Carlos Lehmann, Instituto Nacional de Cancerología
Clínica de Seno y Tejidos Blandos, Instituto Nacional de Cancerología, Bogotá D. C., Colombia
Mauricio, García, Instituto Nacional de Cancerología
Clínica de Seno y Tejidos Blandos, Instituto Nacional de Cancerología, Bogotá D. C., Colombia
Carlos Duarte, Instituto Nacional de Cancerología
Clínica de Seno y Tejidos Blandos, Instituto Nacional de Cancerología, Bogotá D. C., Colombia
Messa Oscar, Instituto Nacional de Cancerología
Patología Oncológica, Departamento de Patología, Instituto Nacional de Cancerología, Bogotá D. C., Colombia
References
Rodríguez Rojas A, Gutierrez R. Revista Colombiana de Cirugía. 1994;9(3):157-62.
Parker SJ, Harries SA. Phyllodes tumours. Postgrad Med J. 2001;77(909):428-35.
https://doi.org/10.1136/pmj.77.909.428
Calhoun KE, Thomas J, Nam Kim J, Lehman CD, Anderson BO. Phyllodes Tumors. En: Harris JR, Lippman ME, Morrow M, Osborne CK, editores. Diseases of the Breast. 4 th Edition ed Lippincott Williams & Wilkins; 2010. p. 782-92.
Belloq JP, Magro G. Fibroepithelial tumours. En: Tavassoli FA, Devilee P, editores. World Health Organisation Classification of Tumours Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon: IARC Press; 2003. p. 99-103.
Huang CC, Liu TP, Cheng SP, Chang YC. Surgical Treatment of Phyllodes Tumor of the Breast with the Trend. Journal of Experimental & Clinical Medicine. 2014;6(5):161-5.
https://doi.org/10.1016/j.jecm.2014.08.002
Bernstein L, Deapen D, Ross RK. The descriptive epidemiology of malignant cystosarcoma phyllodes tumors of the breast. Cancer. 1993;71(10):3020-4.
https://doi.org/10.1002/1097-0142(19930515)71:10<3020::AID-CNCR2820711022>3.0.CO;2-G
Abdulcadir D, Nori J, Meattini I, Giannotti E, Boeri C, Vanzi E, et al. Phyllodes tumours of the breast diagnosed as B3 category on image-guided 14-gauge core biopsy: analysis of 51 cases from a single institution and review of the literature. Eur J Surg Oncol. 2014;40(7):859-64.
https://doi.org/10.1016/j.ejso.2014.02.222
Cabrera G, Monduy R, Frías O, Cabrera C. Tumor phyllodes de la mama. Rev Ciencias Médicas. 2011;15(4):22-31.
Orea-Estudillo D, Jaimes-López L, Bernal-Cano J. Tumor phyllodes en un paciente pediátrico. Informe de un caso y revisión de la literatura. Cirugía y Cirujanos. 2008;76(2):165-8.
Lewitan G, Goldberg C, Serro Rde S, Cabaleiro C, Espora SM. [Phyllodes tumor in an 11 years-old girl: Report of a case]. Arch Argent Pediatr. 2010;108(2):e41-3.
Souza JA, Marques EF, Guatelli C, Girão DS, Queroz T, Graziano L, et al. Malignant phyllodes tumor of the breast: case report. Rev Assoc Med Bras. 2011;57(5):495-7.
https://doi.org/10.1590/S0104-42302011000500003
Nagasawa S, Maeda I, Fukuda T, Wu W, Hayami R, Kojima Y, et al. MED12 exon 2 mutations in phyllodes tumors of the breast. Cancer Med. 2015;4(7):1117-21.
https://doi.org/10.1002/cam4.462
Birch JM, Alston RD, McNally RJ, Evans DG, Kelsey AM, Harris M, et al. Relative frequency and morphology of cancers in carriers of germline TP53 mutations. Oncogene. 2001;20(34):4621-8.
https://doi.org/10.1038/sj.onc.1204621
Orribo O, Rodríguez R, Melgar L, Fernández F, De La Torre F. Tumores Phyllodes de mama: clínica, tratamiento y pronóstico. Hospital Universitario de Canarias, España. Rev chil obstet ginecol. 2011;76(6):389-94.
https://doi.org/10.4067/S0717-75262011000600003
Grau AM, Chakravarthy AB, Chugh R. Phyllodes tumours of the breast. En: Rose BD, editor. UpToDate. Waltham, MA: UpToDate; 2014.
Liuzzi J, Fernández A, Velásquez Y, Rincón N. Cistosarcoma phyllodes bilateral un raro caso. Rev venez oncol. 2010;22(3):187-93.
Ibáñez G, Marambio A, Jans J, Gamboa J, Adonis P, Trewhela R, et al. Tumor filoides de la mama*. Rev Chil Cir. 2010;62(2):119-24.
https://doi.org/10.4067/S0718-40262010000200005
Tan H, Zhang S, Liu H, Peng W, Li R, Gu Y, et al. Imaging findings in phyllodes tumors of the breast. Eur J Radiol. 2012;81(1):e62-9.
https://doi.org/10.1016/j.ejrad.2011.01.085
Kamitani T, Matsuo Y, Yabuuchi H, Fujita N, Nagao M, Kawanami S, et al. Differentiation between benign phyllodes tumors and fibroadenomas of the breast on MR imaging. Eur J Radiol. 2014;83(8):1344-9.
https://doi.org/10.1016/j.ejrad.2014.04.031
Ward ST, Jewkes AJ, Jones BG, Chaudhri S, Hejmadi RK, Ismail T, et al. The sensitivity of needle core biopsy in combination with other investigations for the diagnosis of phyllodes tumours of the breast. Int J Surg. 2012;10(9):527-31.
https://doi.org/10.1016/j.ijsu.2012.08.002
Dillon MF, Quinn CM, McDermott EW, O'Doherty A, O'Higgins N, Hill AD. Needle core biopsy in the diagnosis of phyllodes neoplasm. Surgery. 2006;140(5):779-84.
https://doi.org/10.1016/j.surg.2006.03.022
Ricci MD, Amaral PG, Aoki DS, Oliveira Filho HR, Pinheiro Wda S, Filassi JR, et al. [Ultrasound-guided core needle biopsy for the diagnosis of fibroepithelial breast tumors]. Rev Bras Ginecol Obstet. 2011;33(1):27-30.
https://doi.org/10.1590/S0100-72032011000100004
Pietruszka M, Barnes L. Cystosarcoma phyllodes: a clinicopathologic analysis of 42 cases. Cancer. 1978;41(5):1974-83.
https://doi.org/10.1002/1097-0142(197805)41:5<1974::AID-CNCR2820410543>3.0.CO;2-C
Tan PH, Tse G, Lee A, Simpson JF, Harby AM. Fibroepithelial tumours. En: Lakhani SRIOE, Schnitt SJ, Tan PH, van de Vijver MJ, editores. WHO Classification of Tumours of the Breast. 4 th ed. Lyon: IARC; 2012. p. 142-7.
Parfitt JR, Armstrong C, O'malley F, Ross J, Tuck AB. In-situ and invasive carcinoma within a phyllodes tumor associated with lymph node metastases. World J Surg Oncol. 2004;2:46.
https://doi.org/10.1186/1477-7819-2-46
Ghosh P, Saha K. Ductal carcinoma in situ in a benign phyllodes tumor of breast: A rare presentation. J Nat Sci Biol Med. 2014;5(2):470-2.
https://doi.org/10.4103/0976-9668.136261
Spitaleri G, Toesca A, Botteri E, Bottiglieri L, Rotmensz N, Boselli S, et al. Breast phyllodes tumor: a review of literature and a single center retrospective series analysis. Crit Rev Oncol Hematol. 2013;88(2):427-36.
https://doi.org/10.1016/j.critrevonc.2013.06.005
Guillot E, Couturaud B, Reyal F, Curnier A, Ravinet J, Laé M, et al. Management of phyllodes breast tumors. Breast J. 2011;17(2):129-37.
https://doi.org/10.1111/j.1524-4741.2010.01045.x
Chen WH, Cheng SP, Tzen CY, Yang TL, Jeng KS, Liu CL, et al. Surgical treatment of phyllodes tumors of the breast: retrospective review of 172 cases. J Surg Oncol. 2005;91(3):185-94.
https://doi.org/10.1002/jso.20334
Telli ML, Horst KC, Guardino AE, Dirbas FM, Carlson RW. Phyllodes tumors of the breast: natural history, diagnosis, and treatment. J Natl Compr Canc Netw. 2007;5(3):324-30.
https://doi.org/10.6004/jnccn.2007.0027
Salvadori B, Cusumano F, Del Bo R, Delledonne V, Grassi M, Rovini D, et al. Surgical treatment of phyllodes tumors of the breast. Cancer. 1989;63(12):2532-6.
https://doi.org/10.1002/1097-0142(19890615)63:12<2532::AID-CNCR2820631229>3.0.CO;2-Q
Zurrida S, Bartoli C, Galimberti V, Squicciarini P, Delledonne V, Veronesi P, et al. Which therapy for unexpected phyllode tumour of the breast? Eur J Cancer. 1992;28(2-3):654-7.
https://doi.org/10.1016/S0959-8049(05)80119-4
Onkendi EO, Jimenez RE, Spears GM, Harmsen WS, Ballman KV, Hieken TJ. Surgical treatment of borderline and malignant phyllodes tumors: the effect of the extent of resection and tumor characteristics on patient outcome. Ann Surg Oncol. 2014;21(10):3304-9.
https://doi.org/10.1245/s10434-014-3909-x
Barth RJ. Histologic features predict local recurrence after breast conserving therapy of phyllodes tumors. Breast Cancer Res Treat. 1999;57(3):291-5.
https://doi.org/10.1023/A:1006260225618
Asoglu O, Ugurlu MM, Blanchard K, Grant CS, Reynolds C, Cha SS, et al. Risk factors for recurrence and death after primary surgical treatment of malignant phyllodes tumors. Ann Surg Oncol. 2004;11(11):1011-7.
https://doi.org/10.1245/ASO.2004.02.001
Guerrero MA, Ballard BR, Grau AM. Malignant phyllodes tumor of the breast: review of the literature and case report of stromal overgrowth. Surg Oncol. 2003;12(1):27-37.
https://doi.org/10.1016/S0960-7404(03)00005-7
Hashimoto T, Okishiro M, Ishida T, Sato Y, Morimoto Y, Kusama H, et al. [A case of malignant phyllodes tumor after surgery for breast cancer]. Gan To Kagaku Ryoho. 2014;41(12):1927-9.
Mitu's J, Reinfuss M, Mitu's JW, Jakubowicz J, Blecharz P, Wysocki WM, et al. Malignant phyllodes tumor of the breast: treatment and prognosis. Breast J. 2014;20(6):639-44.
https://doi.org/10.1111/tbj.12333
Macdonald OK, Lee CM, Tward JD, Chappel CD, Gaffney DK. Malignant phyllodes tumor of the female breast: association of primary therapy with cause-specific survival from the Surveillance, Epidemiology, and End Results (SEER) program. Cancer. 2006;107(9):2127-33.
https://doi.org/10.1002/cncr.22228
August DA, Kearney T. Cystosarcoma phyllodes: mastectomy, lumpectomy, or lumpectomy plus irradiation. Surg Oncol. 2000;9(2):49-52.
https://doi.org/10.1016/S0960-7404(00)00022-0
Abdalla HM, Sakr MA. Predictive factors of local recurrence and survival following primary surgical treatment of phyllodes tumors of the breast. J Egypt Natl Canc Inst. 2006;18(2):125-33.
Kapiris I, Nasiri N, A'Hern R, Healy V, Gui GP. Outcome and predictive factors of local recurrence and distant metastases following primary surgical treatment of high-grade malignant phyllodes tumours of the breast. Eur J Surg Oncol. 2001;27(8):723-30.
https://doi.org/10.1053/ejso.2001.1207
Chaney AW, Pollack A, McNeese MD, Zagars GK, Pisters PW, Pollock RE, et al. Primary treatment of cystosarcoma phyllodes of the breast. Cancer. 2000;89(7):1502-11.
https://doi.org/10.1002/1097-0142(20001001)89:7<1502::AID-CNCR13>3.0.CO;2-P
Gnerlich JL, Williams RT, Yao K, Jaskowiak N, Kulkarni SA. Utilization of radiotherapy for malignant phyllodes tumors: analysis of the National Cancer Data Base, 1998-2009. Ann Surg Oncol. 2014;21(4):1222-30.
https://doi.org/10.1245/s10434-013-3395-6
Barth RJ, Wells WA, Mitchell SE, Cole BF. A prospective, multi-institutional study of adjuvant radiotherapy after resection of malignant phyllodes tumors. Ann Surg Oncol. 2009;16(8):2288-94.
https://doi.org/10.1245/s10434-009-0489-2
Hawkins RE, Schofield JB, Wiltshaw E, Fisher C, McKinna JA. Ifosfamide is an active drug for chemotherapy of metastatic cystosarcoma phyllodes. Cancer. 1992;69(9):2271-5.
https://doi.org/10.1002/1097-0142(19920501)69:9<2271::AID-CNCR2820690911>3.0.CO;2-7
Morales-Vásquez F, Gonzalez-Angulo AM, Broglio K, Lopez- Basave HN, Gallardo D, Hortobagyi GN, et al. Adjuvant chemotherapy with doxorubicin and dacarbazine has no effect in recurrence-free survival of malignant phyllodes tumors of the breast. Breast J. 2007;13(6):551-6.
https://doi.org/10.1111/j.1524-4741.2007.00510.x
Sapino A, Bosco M, Cassoni P, Castellano I, Arisio R, Cserni G, et al. Estrogen receptor-beta is expressed in stromal cells of fibroadenoma and phyllodes tumors of the breast. Mod Pathol. 2006;19(4):599-606.
https://doi.org/10.1038/modpathol.3800574
Wang H, Wang X, Wang CF. Comparison of clinical characteristics between benign borderline and malignant phyllodes tumors of the breast. Asian Pac J Cancer Prev. 2014;15(24):10791-5.
https://doi.org/10.7314/APJCP.2014.15.24.10791
Lightner AL, Shurell E, Dawson N, Omidvar Y, Foster N. A singlecenter experience and review of the literature: 64 cases of phyllodes tumors to better understand risk factors and disease management. Am Surg. 2015;81(3):309-15.
How to Cite
Downloads
Downloads
Published
Issue
Section
License
Todos los derechos reservados.
Article metrics | |
---|---|
Abstract views | |
Galley vies | |
PDF Views | |
HTML views | |
Other views |